Skip to content

effect of selenium on oxidative stress status and inflammatory factors in post gastrointestinal surgery children

Evaluation of the effect of high doses of selenium on oxidative stress status and inflammatory factors in post gastrointestinal surgery children in intensive care unit

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190122042449N1
Enrollment
70
Registered
2019-01-27
Start date
2019-02-06
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Digestive System Surgical Procedures. Condition 2: selenium deficiency. Condition 3: Congenital diaphragmatic hernia. Condition 4: Acute abdomen. Condition 5: Congenital malformations of esophagus. Condition 6: Other specified congenital malformations of upper alimentary tract. Condition 7: Congenital disorders of small intestine. Condition 8: Congenital disorders of large intestine. Condition 9: Congenital malformations of gallbladder, bile ducts and liver. Unspecified intestinal

Interventions

Intervention 1: Intervention group: Selenium supplementation will continue to be given at a dose of 20 µg / kg / d for 10 days or until discharge from the intensive care unit or death. High-dose selen

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 10 Years

Inclusion criteria

Inclusion criteria: 0-10 years old patients undergoing major gastrointestinal surgery at the Akbar Hospital of Mashhad Admission to the intensive care unit due to medical indications Filling out the informed consent form by a parent or legal guardian Stability of hemodynamic and metabolic status in the first 24 to 48 hours

Exclusion criteria

Exclusion criteria: Patients who are not allowed to start a nutrition support care for them within the first 24-48 hours Diagnosed autoimmune disorders Diagnosed cancers Severe sepsis at the admission time History of chemotherapy and radiotherapy in the past month Diagnosed renal failure Diagnosed severe hepatic failure Severe and active bleeding A known case of human immunodeficiency virus Preterm neonates

Design outcomes

Primary

MeasureTime frame
Pro-oxidant- Antioxidant Balance (PAB) status. Timepoint: before intervention and after 10 days. Method of measurement: Pro-oxidant- Antioxidant Balance (PAB) assay.;Inflammatory factors. Timepoint: before intervention and after 10 days. Method of measurement: Interleukin 1 beta: ELISA, high-sensitivity C-reactive protein (hs-CRP) test: Immunoturbidimetry.

Secondary

MeasureTime frame
Serum and urine selenium Level. Timepoint: before intervention and 1, 10 days after intervention. Method of measurement: atomic absorpsion.;Serum Glutathione peroxidase level. Timepoint: before intervention and 1, 10 days after intervention. Method of measurement: ELISA.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Roudi

Mashhad University of Medical Sciences

roudif951@mums.ac.ir+98 51 3800 2423

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026